Patrick Marcellin
1,180 works · 71,259 citations · h-index 129
Top works
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
- Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B
- Long-Term Histologic Improvement and Loss of Detectable Intrahepatic HCV RNA in Patients with Chronic Hepatitis C and Sustained Response to Interferon-α Therapy
- Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
- Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
- Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from France
- Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C
- Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B
- Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
- Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years
- Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1 ☆
- Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases
- Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC
- EASL International Consensus Conference on Hepatitis C